More than 3 million Medicare patients could be eligible for coverage of Wegovy to reduce heart disease risks, study says
Related Articles
-
Eli Lilly Stock Surges as Weight Loss Drugs Continue to Fuel Growth
Eli Lilly shares jumped in early trading Tuesday as the drugmaker reported first-quarter earnings above expectations and raised full year...
-
Why Eli Lilly's earnings are no sure thing for traders despite obesity drug momentum
The Food and Drug Administration said supplies of Zepbound and Mounjaro are expected to be limited through the second quarter, for all but one dosage.
-
Man says property raided by SWAT wasn’t base for drug trafficking
MEMPHIS, Tenn. — As more information comes out about Friday’s narcotic warrant that ended with a man being killed and three people behind bars, WREG spoke with someone who said some of